Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Amitraz effectively treated sarcoptic mange in three alpacas.

Aminexil clinical 5 effectively reduces hair loss and is well-tolerated.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Stopping imipramine reduced the woman's hair loss.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.